Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
iVoice, Inc. Announces Intention to Spin Off Thomas Pharmaceuticals Ltd. To Shareholders
April 11th, 2007
iVoice, Inc. (OTC Bulletin Board: IVOI), announced that it intends to distribute to the Company's shareholders shares of common stock of its subsidiary Thomas Pharmaceuticals Ltd. When completed, this would be the fifth common stock subsidiary dividend issued by the Company to its shareholders including Trey Resources, Inc., iVoice Technology, Inc., SpeechSwitch, Inc. and. DeepField Technologies, Inc. The iVoice board of directors authorized management to pursue a strategy designed to unlock the value in the Thomas Pharmaceuticals Acid+All(R) product line. Subject to final review by the SEC, holders of iVoice common stock will receive shares of...
Source: Medical Patent Law Weekly (2007-04-11)
|